Business
Assertio to Participate in October 2022 Investor Conferences
LAKE FOREST, Ill., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company
About this update from Assertio Holdings, Inc.
[{"type":"text","content":"LAKE FOREST, Ill., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (\"Assertio\" or the \"Company\") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that management will participate at the following investor conference events during October 2022. Event:Windy City Roundup 2022Date:Thursday, October 13, 2022Presentation:11:00 a.m. Central TimeLocation:Swissotel, Chicago Event:LD Micro Main Event XVDate:Tuesday, October 25, 2022Presentation:10:30 a.m. Pacific TimeLive stream:https://me22.mysequire.com/ Location:Luxe Sunset Boulevard Hotel, Los Angeles As part of the conference events, management will host one-on-one meetings throughout the day. For more information about scheduling a one-on-one meeting with management, please contact your institutional representative for the respective events or Matt Kreps, Investor Relations for Assertio Holdings, at [email protected]. About Assertio Assertio Holdings, Inc. is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. For more information regarding Assertio Holdings, go to: https://www.assertiotx.com/. Investor Contact:Matt KrepsManaging DirectorDarrow AssociatesAustin, TXM: [email protected] \nSource: Assertio Holdings, Inc.","length":5570,"tagName":"div"}]